Have a personal or library account? Click to login
Design, synthesis, and evaluation of a novel fluorescent probe for competitive fluorescence polarization assay to screen galectin-8 inhibitors Cover

Design, synthesis, and evaluation of a novel fluorescent probe for competitive fluorescence polarization assay to screen galectin-8 inhibitors

Open Access
|Jul 2025

References

  1. Y. Vinik, H. Shatz-Azoulay and Y. Zick, Molecular mechanisms underlying the role of galectin-8 as a regulator of cancer growth and metastasis, Trends Glycosci. Glycotechnol. 30(172) (2018) SE119– SE128; https://doi.org/10.4052/tigg.1742.1SE
  2. Y. R. Hadari, K. Paz, R. Dekel, T. Mestrovic, D. Accili and Y. Zick, Galectin-8: A new rat lectin, re-lated to galectin-4, J. Biol. Chem. 270(7) (1995) 3447–3453; https://doi.org/10.1074/jbc.270.7.3447
  3. Y. R. Hadari, R. Arbel-Goren, Y. Levy, A. Amsterdam, R. Alon, R. Zakut and Y. Zick, Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis, J. Cell Sci. 113(13) (2000) 2385–2397; https://doi.org/10.1242/jcs.113.13.2385
  4. R. V. Gopalkrishnan, T. Roberts, S. Tuli, D. C. Kang, K. A. Christiansen and P. B. Fisher, Molecular characterization of prostate carcinoma tumor antigen-1, PCTA-1, a human galectin-8 related gene, Oncogene 19(38) (2000) 4405–4416; https://doi.org/10.1038/sj.onc.1203767
  5. R. D. Cummings, F.-T. Liu, G. A. Rabinovich, S. R. Stowell and G. R. Vasta, Galectins, in Carbohydrates in Chemistry and Biology 4–4, Wiley Online Library, 2022, pp. 625–647; https://doi.org/10.1002/9783527618255
  6. E. Purić, U. J. Nilsson and M. Anderluh, Galectin-8 inhibition and functions in immune response and tumor biology, Med. Res. Rev. 44(5) (2024) 2236–2265; https://doi.org/10.1002/med.22041
  7. P. Sörme, B. Kahl-Knutson, U. Wellmar, U. J. Nilsson and H. Leffler, Fluorescence polarization to study galectin-ligand interactions, Methods Enzymol. 362 (2003) 504–512; https://doi.org/10.1016/S0076-6879(03)01033-4
  8. P. Sörme, B. Kahl-Knutson, M. Huflejt, U. J. Nilsson and H. Leffler, Fluorescence polarization as an analytical tool to evaluate galectin-ligand interactions, Anal. Biochem. 334 (2004) 36–47; https://doi.org/10.1016/j.ab.2004.06.042
  9. S. Carlsson, C. T. Öberg, M. C. Carlsson, A. Sundin, U. J. Nilsson, D. Smith, R. D. Cummings, J. Almkvist, A. Karlsson and H. Leffler, Affinity of galectin-8 and its carbohydrate recognition do-mains for ligands in solution and at the cell surface, Glycobiology 17(6) (2007) 663–676; https://doi.org/10.1093/glycob/CWM026
  10. C. T. Öberg, S. Carlsson, E. Fillion, H. Leffler and U. J. Nilsson, Efficient and expedient two-step pyranose-retaining fluorescein conjugation of complex reducing oligosaccharides: Galectin oligo-saccharide specificity studies in a fluorescence polarization assay, Bioconjug. Chem. 14(6) (2003) 1289–1297; https://doi.org/10.1021/bc034130J
  11. W. A. Lea and A. Simeonov, Fluorescence polarization assays in small molecule screening, Expert Opin. Drug Discov. 6(1) (2011) 17–32; https://doi.org/10.1517/17460441.2011.537322
  12. M. D. Hall, A. Yasgar, T. Peryea, J. C. Braisted, A. Jadhav, A. Simeonov and N. P. Coussens, Fluores-cence polarization assays in high-throughput screening and drug discovery: A review, Methods Appl. Fluoresc. 4(2) (2016) Article ID 022001; https://doi.org/10.1088/2050-6120/4/2/022001
  13. E. A. Howe, A. De Souza, D. L. Lahr, S. Chatwin, P. Montgomery, B. R. Alexander, D. T. Nguyen, Y. Cruz, D. A. Stonich, G. Walzer, J. T. Rose, S. C. Picard, Z. Liu, J. N. Rose, X. Xiang, J. Asiedu, D. Dur-kin, J. Levine, J. J. Yang, S. C. Schürer, J. C. Braisted, N. Southall, M. R. Southern, T. D. Y. Chung, S. Brudz, C. Tanega, S. L. Schreiber, J. A. Bittker, R. Guha and P. A. Clemons, BioAssay Research Data-base (BARD): chemical biology and probe-development enabled by structured metadata and result types, Nucleic Acids Res. 43 (2015) D1163–D1170; https://doi.org/10.1093/nar/gku1244
  14. E. Purić, M. Hassan, F. Sjövall, T. Tomašič, M. Pevec, J. Lah, J. A. Forteza, A. Sundin, H. Leffler, U. J. Nilsson, D. T. Logan and M. Anderluh, Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction, Commun. Chem. 8(1) (2025) Article ID 59 (11 pages); https://doi.org/10.1038/s42004-025-01458-6
  15. K. B. Pal, M. Mahanti, X. Huang, S. Persson, A. P. Sundin, F. R. Zetterberg, S. Oredsson, H. Leffler and U. J. Nilsson, Quinoline-galactose hybrids bind selectively with high affinity to a galectin-8 N-terminal domain, Org. Biomol. Chem. 16(34) (2018) 6295–6305; https://doi.org/10.1039/C8OB01354C
  16. M. Hassan, S. van Klaveren, M. Håkansson, C. Diehl, R. Kovačič, F. Baussière, A. P. Sundin, J. Dernovšek, B. Walse, F. Zetterberg, H. Leffler, M. Anderluh, T. Tomašič, Ž. Jakopin and U. J. Nilsson, Benzimidazole-galactosides bind selectively to the galectin-8 N-terminal domain: Structure-based design and optimisation, Eur. J. Med. Chem. 223 (2021) Article ID 113664 (13 pages); https://doi.org/10.1016/j.ejmech.2021.113664
  17. M. Hassan, F. Baussière, S. Guzelj, A. P. Sundin, M. Håkansson, R. Kovačič, H. Leffler, T. Tomašič, M. Anderluh, Ž. Jakopin and U. J. Nilsson, Structure-guided design of d -galactal derivatives with high affinity and selectivity for the galectin-8 N-terminal domain, ACS Med. Chem. Lett. 12(11) (2021) 1745–1752; https://doi.org/10.1021/acsmedchemlett.1c00371
  18. B. Girardi, M. Manna, S. Van Klaveren, T. Tomašič, Ž. Jakopin, H. Leffler, U. J. Nilsson, D. Ricklin, J. Mravljak, O. Schwardt and M. Anderluh, Selective monovalent galectin-8 ligands based on 3-lact-oylgalactoside, ChemMedChem 17(3) (2022) Article ID e202100514; https://doi.org/10.1002/cmdc.202100514
  19. K. M. Craft and S. D. Townsend, Synthesis of lacto-N-tetraose, Carbohydr. Res. 440–441 (2017) 43–50; https://doi.org/10.1016/j.carres.2017.02.001
  20. J. H. Zhang, T. D. Y. Chung and K. R. Oldenburg, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, SLAS Discovery 4(2) (1999) 67–73; https://doi.org/10.1177/108705719900400206
DOI: https://doi.org/10.2478/acph-2025-0010 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 273 - 282
Accepted on: Mar 27, 2025
Published on: Jul 3, 2025
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2025 Edvin Purić, Marina Marinović, Zala Kojek, Barbro Kahl-Knutson, Hakon Leffler, Ulf J. Nilsson, Marko Anderluh, Janez Mravljak, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.